Close Menu

NEW YORK (360Dx) – Melinta Therapeutics said this week that the US Food and Drug Administration has cleared three antimicrobial susceptibility tests to help guide physicians in the use of Melinta's drug to treatment for bacterial skin and skin structure infections.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.